Vontobel Holding’s BioCardia BCDA Stock Holding History

Vontobel Holding’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,050	Closed	-$82.1K	–	1073
2023 Q2	$82.1K	Buy	2,050 +990	+93%	+$30.5K	﹤0.01%	1057
2023 Q1	$31.2K	Buy	+1,060	New	+$35.2K	﹤0.01%	1057

Other funds holding BCDA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Family Management New York $975M AUM 23.16% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Vontobel Holding's BCDA Position: Q3 2023 in Review

Vontobel Holding sold out of BioCardia (BCDA) in Q3 2023, closing a stake of 2,050 shares — an estimated $82.1K sold.

Vontobel Holding first reported a position in BCDA in Q1 2023 and held it in 2 quarters. The position peaked at $82.1K in Q2 2023. 16 funds tracked by Wall St. Rank hold BCDA as of Q3 2023.

Vontobel Holding reported no remaining BioCardia position as of Q3 2023 after selling out during the quarter.
Vontobel Holding sold 2,050 BioCardia shares in Q3 2023, an estimated $82.1K.
Vontobel Holding first reported a position in BioCardia in Q1 2023 and held it in 2 quarters.
Vontobel Holding's BioCardia position peaked at $82.1K in Q2 2023.
16 funds tracked by Wall St. Rank held BioCardia as of Q3 2023.

Based on Vontobel Holding's 13F filing for Q3 2023, filed 11 Oct 2023.